Cargando…

Benzene Exposure Leads to Lipodystrophy and Alters Endocrine Activity In Vivo and In Vitro

Benzene is a ubiquitous pollutant and mainly accumulates in adipose tissue which has important roles in metabolic diseases. The latest studies reported that benzene exposure was associated with many metabolic disorders, while the effect of benzene exposure on adipose tissue remains unclear. We sough...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Ying, Mo, Ziying, Ji, Penglei, Zhong, Jingyi, Li, Zongxin, Li, Daochuan, Qin, Lina, Liao, Qilong, He, Zhini, Guo, Wei, Chen, Liping, Wang, Qing, Dong, Guanghui, Chen, Wen, Xiao, Yongmei, Xing, Xiumei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326257/
https://www.ncbi.nlm.nih.gov/pubmed/35909554
http://dx.doi.org/10.3389/fendo.2022.937281
_version_ 1784757243016642560
author Cui, Ying
Mo, Ziying
Ji, Penglei
Zhong, Jingyi
Li, Zongxin
Li, Daochuan
Qin, Lina
Liao, Qilong
He, Zhini
Guo, Wei
Chen, Liping
Wang, Qing
Dong, Guanghui
Chen, Wen
Xiao, Yongmei
Xing, Xiumei
author_facet Cui, Ying
Mo, Ziying
Ji, Penglei
Zhong, Jingyi
Li, Zongxin
Li, Daochuan
Qin, Lina
Liao, Qilong
He, Zhini
Guo, Wei
Chen, Liping
Wang, Qing
Dong, Guanghui
Chen, Wen
Xiao, Yongmei
Xing, Xiumei
author_sort Cui, Ying
collection PubMed
description Benzene is a ubiquitous pollutant and mainly accumulates in adipose tissue which has important roles in metabolic diseases. The latest studies reported that benzene exposure was associated with many metabolic disorders, while the effect of benzene exposure on adipose tissue remains unclear. We sought to investigate the effect using in vivo and in vitro experiments. Male adult C57BL/6J mice were exposed to benzene at 0, 1, 10 and 100 mg/kg body weight by intragastric gavage for 4 weeks. Mature adipocytes from 3T3-L1 cells were exposed to hydroquinone (HQ) at 0, 1, 5 and 25 μM for 24 hours. Besides the routine hematotoxicity, animal experiments also displayed significant body fat content decrease from 1 mg/kg. Interestingly, the circulating non-esterified fatty acid (NEFA) level increased from the lowest dose (p (trend) < 0.05). Subsequent analysis indicated that body fat content decrease may be due to atrophy of white adipose tissue (WAT) upon benzene exposure. The average adipocyte area of WAT decreased significantly even from 1 mg/kg with no significant changes in total number of adipocytes. The percentages of small and large adipocytes in WAT began to significantly increase or decrease from 1 mg/kg (all p < 0.05), respectively. Critical genes involved in lipogenesis and lipolysis were dysregulated, which may account for the disruption of lipid homeostasis. The endocrine function of WAT was also disordered, manifested as significant decrease in adipokine levels, especially the leptin. In vitro cell experiments displayed similar findings in decreased fat content, dysregulated critical lipid metabolism genes, and disturbed endocrine function of adipocytes after HQ treatment. Pearson correlation analysis showed positive correlations between white blood cell (WBC) count with WAT fat content and plasma leptin level (r = 0.330, 0.344, both p < 0.05). This study shed light on the novel aspect that benzene exposure could induce lipodystrophy and disturb endocrine function of WAT, and the altered physiology of WAT might in turn affect benzene-induced hematotoxicity and metabolic disorders. The study provided new insight into understanding benzene-induced toxicity and the relationship between benzene and adipose tissue.
format Online
Article
Text
id pubmed-9326257
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93262572022-07-28 Benzene Exposure Leads to Lipodystrophy and Alters Endocrine Activity In Vivo and In Vitro Cui, Ying Mo, Ziying Ji, Penglei Zhong, Jingyi Li, Zongxin Li, Daochuan Qin, Lina Liao, Qilong He, Zhini Guo, Wei Chen, Liping Wang, Qing Dong, Guanghui Chen, Wen Xiao, Yongmei Xing, Xiumei Front Endocrinol (Lausanne) Endocrinology Benzene is a ubiquitous pollutant and mainly accumulates in adipose tissue which has important roles in metabolic diseases. The latest studies reported that benzene exposure was associated with many metabolic disorders, while the effect of benzene exposure on adipose tissue remains unclear. We sought to investigate the effect using in vivo and in vitro experiments. Male adult C57BL/6J mice were exposed to benzene at 0, 1, 10 and 100 mg/kg body weight by intragastric gavage for 4 weeks. Mature adipocytes from 3T3-L1 cells were exposed to hydroquinone (HQ) at 0, 1, 5 and 25 μM for 24 hours. Besides the routine hematotoxicity, animal experiments also displayed significant body fat content decrease from 1 mg/kg. Interestingly, the circulating non-esterified fatty acid (NEFA) level increased from the lowest dose (p (trend) < 0.05). Subsequent analysis indicated that body fat content decrease may be due to atrophy of white adipose tissue (WAT) upon benzene exposure. The average adipocyte area of WAT decreased significantly even from 1 mg/kg with no significant changes in total number of adipocytes. The percentages of small and large adipocytes in WAT began to significantly increase or decrease from 1 mg/kg (all p < 0.05), respectively. Critical genes involved in lipogenesis and lipolysis were dysregulated, which may account for the disruption of lipid homeostasis. The endocrine function of WAT was also disordered, manifested as significant decrease in adipokine levels, especially the leptin. In vitro cell experiments displayed similar findings in decreased fat content, dysregulated critical lipid metabolism genes, and disturbed endocrine function of adipocytes after HQ treatment. Pearson correlation analysis showed positive correlations between white blood cell (WBC) count with WAT fat content and plasma leptin level (r = 0.330, 0.344, both p < 0.05). This study shed light on the novel aspect that benzene exposure could induce lipodystrophy and disturb endocrine function of WAT, and the altered physiology of WAT might in turn affect benzene-induced hematotoxicity and metabolic disorders. The study provided new insight into understanding benzene-induced toxicity and the relationship between benzene and adipose tissue. Frontiers Media S.A. 2022-07-13 /pmc/articles/PMC9326257/ /pubmed/35909554 http://dx.doi.org/10.3389/fendo.2022.937281 Text en Copyright © 2022 Cui, Mo, Ji, Zhong, Li, Li, Qin, Liao, He, Guo, Chen, Wang, Dong, Chen, Xiao and Xing https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Cui, Ying
Mo, Ziying
Ji, Penglei
Zhong, Jingyi
Li, Zongxin
Li, Daochuan
Qin, Lina
Liao, Qilong
He, Zhini
Guo, Wei
Chen, Liping
Wang, Qing
Dong, Guanghui
Chen, Wen
Xiao, Yongmei
Xing, Xiumei
Benzene Exposure Leads to Lipodystrophy and Alters Endocrine Activity In Vivo and In Vitro
title Benzene Exposure Leads to Lipodystrophy and Alters Endocrine Activity In Vivo and In Vitro
title_full Benzene Exposure Leads to Lipodystrophy and Alters Endocrine Activity In Vivo and In Vitro
title_fullStr Benzene Exposure Leads to Lipodystrophy and Alters Endocrine Activity In Vivo and In Vitro
title_full_unstemmed Benzene Exposure Leads to Lipodystrophy and Alters Endocrine Activity In Vivo and In Vitro
title_short Benzene Exposure Leads to Lipodystrophy and Alters Endocrine Activity In Vivo and In Vitro
title_sort benzene exposure leads to lipodystrophy and alters endocrine activity in vivo and in vitro
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326257/
https://www.ncbi.nlm.nih.gov/pubmed/35909554
http://dx.doi.org/10.3389/fendo.2022.937281
work_keys_str_mv AT cuiying benzeneexposureleadstolipodystrophyandaltersendocrineactivityinvivoandinvitro
AT moziying benzeneexposureleadstolipodystrophyandaltersendocrineactivityinvivoandinvitro
AT jipenglei benzeneexposureleadstolipodystrophyandaltersendocrineactivityinvivoandinvitro
AT zhongjingyi benzeneexposureleadstolipodystrophyandaltersendocrineactivityinvivoandinvitro
AT lizongxin benzeneexposureleadstolipodystrophyandaltersendocrineactivityinvivoandinvitro
AT lidaochuan benzeneexposureleadstolipodystrophyandaltersendocrineactivityinvivoandinvitro
AT qinlina benzeneexposureleadstolipodystrophyandaltersendocrineactivityinvivoandinvitro
AT liaoqilong benzeneexposureleadstolipodystrophyandaltersendocrineactivityinvivoandinvitro
AT hezhini benzeneexposureleadstolipodystrophyandaltersendocrineactivityinvivoandinvitro
AT guowei benzeneexposureleadstolipodystrophyandaltersendocrineactivityinvivoandinvitro
AT chenliping benzeneexposureleadstolipodystrophyandaltersendocrineactivityinvivoandinvitro
AT wangqing benzeneexposureleadstolipodystrophyandaltersendocrineactivityinvivoandinvitro
AT dongguanghui benzeneexposureleadstolipodystrophyandaltersendocrineactivityinvivoandinvitro
AT chenwen benzeneexposureleadstolipodystrophyandaltersendocrineactivityinvivoandinvitro
AT xiaoyongmei benzeneexposureleadstolipodystrophyandaltersendocrineactivityinvivoandinvitro
AT xingxiumei benzeneexposureleadstolipodystrophyandaltersendocrineactivityinvivoandinvitro